Reviparin reduces reinfarction, mortality after MI

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1464, 2004-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eplerenone reduces morbidity, mortality after acute MI

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Acadesine reduces 2-year mortality risk in post-reperfusion MI

By  

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Pexelizumab: reduced mortality rate after acute MI

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Pexelizumab: lower MI, mortality rates after CABG

By  

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Reviparin as prophylaxis for thromboembolism after leg injury and hip replacement

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 2, 2003-02 ,pp. : 285-288

Informa Healthcare

Access to resources Recommend Favorite